(81 days)
Not Found
No
The document describes a mechanical drainage system and does not mention any software, algorithms, or data processing that would indicate the use of AI/ML.
Yes
The device is indicated for "intermittent, long term drainage of symptomatic, recurrent, malignant ascites... for the palliation of symptoms related to recurrent malignant ascites". Palliation of symptoms is a therapeutic function.
No.
The device is indicated for the palliation of symptoms related to recurrent malignant ascites through drainage, and aiding in catheter insertion and dressing. It does not mention any function for diagnosing conditions.
No
The device description clearly lists physical components like a catheter and drainage kits, indicating it is a hardware-based medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes a system for draining fluid from the peritoneal space to relieve symptoms of malignant ascites. This is a therapeutic intervention, not a diagnostic test performed on samples outside the body.
- Device Description: The device components are a catheter and drainage kits, designed for physically removing fluid. This aligns with a therapeutic device, not a diagnostic one.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or providing information about a patient's health status based on such analysis. The device's function is purely mechanical drainage.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Pleurx Peritoneal Catheter System does not fit this description.
N/A
Intended Use / Indications for Use
The Pleurx Peritoneal Catheter System is indicated for intermittent, long term drainage of symptomatic, recurrent, malignant ascites that does not respond to medical management of the underlying disease, for the palliation. of symptoms related to recurrent malignant ascites and for peritoneal placement only.
The Pleurx Drainage Bottle Kits and Drainage Line Set are indicated for use either with the Pleurx Peritoneal Catheter or Pleurx Pleural Catheter for intermittent drainage. The Drainage Line Kit is used to drain fluid using standard wall suction, water seal drainage system, vacuum bottle or other appropriate method.
The Pleurx Drainage Bag Kit is indicated for use only with the Pleurx Peritoneal Catheter for intermittent drainage.
The Pleurx Dressing Kits are indicated for dressing of a catheter and exit site.
The Pleurx Catheter Insertion Stylet is intended to aid in the percutaneous insertion of the Pleurx Catheter into the peritoneal space.
Product codes (comma separated list FDA assigned to the subject device)
PNG, FJS
Device Description
The Pleurx Peritoneal Catheter System provides patients with a convenient method to relieve malignant ascites symptoms at home. The primary components of the Pleurx Catheter System are the Pleurx Peritoneal Catheter and the Pleurx Drainage Kits.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
peritoneal
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical tests were conducted. The results show that the CareFusion Pleurx Periloneal Catheter System meets or exceed all performance requirements, and are substantially equivalent to the predicate devices. No clinical tests were conducted for this submission.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5630 Peritoneal dialysis system and accessories.
(a)
Identification. (1) A peritoneal dialysis system and accessories is a device that is used as an artificial kidney system for the treatment of patients with renal failure or toxemic conditions, and that consists of a peritoneal access device, an administration set for peritoneal dialysis, a source of dialysate, and, in some cases, a water purification mechanism. After the dialysate is instilled into the patient's peritoneal cavity, it is allowed to dwell there so that undesirable substances from the patient's blood pass through the lining membrane of the peritoneal cavity into this dialysate. These substances are then removed when the dialysate is drained from the patient. The peritoneal dialysis system may regulate and monitor the dialysate temperature, volume, and delivery rate together with the time course of each cycle of filling, dwell time, and draining of the peritoneal cavity or manual controls may be used. This generic device includes the semiautomatic and the automatic peritoneal delivery system.(2) The peritoneal access device is a flexible tube that is implanted through the abdominal wall into the peritoneal cavity and that may have attached cuffs to provide anchoring and a skin seal. The device is either a single use peritioneal catheter, intended to remain in the peritoneal cavity for less than 30 days, or a long term peritoneal catheter. Accessories include stylets and trocars to aid in the insertion of the catheter and an obturator to maintain the patency of the surgical fistula in the abdominal wall between treatments.
(3) The disposable administration set for peritoneal dialysis consists of tubing, an optional reservoir bag, and appropriate connectors. It may include a peritoneal dialysate filter to trap and remove contaminating particles.
(4) The source of dialysate may be sterile prepackaged dialysate (for semiautomatic peritoneal dialysate delivery systems or “cycler systems”) or dialysate prepared from dialysate concentrate and sterile purified water (for automatic peritoneal dialysate delivery systems or “reverse osmosis” systems). Prepackaged dialysate intended for use with either of the peritoneal dialysate delivery systems is regulated by FDA as a drug.
(b)
Classification. Class II (special controls). The following accessories are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9: A catheter finger grip that is non-patient contacting and intended for single use with a peritoneal catheter; a continuous ambulatory peritoneal dialysis (CAPD) belt; and a catheter stand that does not include weigh scales.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles a human figure embracing or being embraced by three wavy lines, which may represent support or care.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 18, 2017
CareFusion Joy Greidanus Regulatory Affairs Manager 1500 Waukegan Road Waukegan, IL 60085
Re: K113854
Trade/Device Name: Pleurx Peritoneal Catheter System Regulation Number: 21 CFR §876.5630 Regulation Name: Peritoneal dialysis system and accessories Regulatory Class: II Product Code: PNG Dated: December 22, 2011 Received: December 29, 2011
Dear Joy Greidanus:
This letter corrects our substantially equivalent letter of March 19, 2012.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
1
Page 2 - Joy Greidanus
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Benjamin R. Fisher -S
Benjamin R. Fisher, Ph.D. Director Division of Reproductive. Gastro-Renal. and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
CareFusion - December 2011 - Traditional 510(k): Pleurx Peritoneal Catheter System
Image /page/2/Picture/1 description: The image shows the CareFusion logo. The logo consists of a circular icon on the left and the text "CareFusion" on the right. The icon appears to be a stylized shield or emblem with a checkmark-like shape inside.
1500 Waukegan Road McGaw Park, Illinois 60085-6787 847.473.7404 FAX: 847.473.7790
Indication for Use
510(k) Number (if known):
Device Name:
Pleurx Peritoneal Catheter System
Indications for Use:
The Pleurx Peritoneal Catheter System is indicated for intermittent, long term drainage of symptomatic, recurrent, malignant ascites that does not respond to medical management of the underlying disease, for the palliation. of symptoms related to recurrent malignant ascites and for peritoneal placement only.
The Pleurx Drainage Bottle Kits and Drainage Line Set are indicated for use either with the Pleurx Peritoneal Catheter or Pleurx Pleural Catheter for intermittent drainage. The Drainage Line Kit is used to drain fluid using standard wall suction, water seal drainage system, vacuum bottle or other appropriate method.
The Pleurx Drainage Bag Kit is indicated for use only with the Pleurx Peritoneal Catheter for intermittent drainage.
The Pleurx Dressing Kits are indicated for dressing of a catheter and exit site.
The Pleurx Catheter Insertion Stylet is intended to aid in the percutaneous insertion of the Pleurx Catheter into the peritoneal space.
Prescription Use X (Per 21 CFR 801.109) or Over-The Counter Use
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Heilb. Lewe
| (Division' Sign-Off) |
|---|
| ---------------------- |
Division of Reproductive, Gastro-Renal, and
Urological Devices
| 510(k) Number | K113854 |
|---|---|
| --------------- | --------- |
3
3
Aige 1.93
CareFusion – December 2011 - Traditional 510(k): Pleurx Peritoneal Catheter System
Image /page/3/Picture/2 description: The image contains the logo for CareFusion. The logo consists of a circular graphic to the left of the company name. The graphic contains a stylized design of interconnected shapes within a circle. The text "CareFusion" is written in a bold, sans-serif font.
.
MAR 1 9 2012
510(k) SUMMARY K113854
A summary of 510(k) safety and effectiveness information in accordance with 21CFR 807.92.
| SUBMITTER INFORMATION | ||
|---|---|---|
| Name | CareFusion | |
| Address | 1500 Waukegan Road MPWM, McGaw Park, IL 60085 USA | |
| Phone number | (847) 473-7404 | |
| Fax number | (847) 473-7790 | |
| Establishment | ||
| Registration Number | 1423507 | |
| Name of contact person | Joy Greidanus | |
| Date prepared | December 22, 2011 | |
| NAME OF DEVICE | ||
| Trade or proprietary | ||
| name | Pleurx Peritoneal Catheter System | |
| Common or usual name | Catheter, peritoneal, long-term, indwelling | |
| Classification name | Peritoneal dialysis system and accessories | |
| Classification panel | Gastroenterology/Urology | |
| Regulation | Class II per 21CFR §876.5630, Procode FJS | |
| Product Code(s) | Multiple | |
| Legally marketed | ||
| device(s) to which | ||
| equivalence is claimed | CareFusion Pleurx Peritoneal Catheter Kit and Drainage Kits: K051711 | |
| Bard Aspira Peritoneal Drainage System: K110396 | ||
| Device description | The Pleurx Peritoneal Catheter System provides patients with a convenient | |
| method to relieve malignant ascites symptoms at home. The primary | ||
| components of the Pleurx Catheter System are the Pleurx Peritoneal | ||
| Catheter and the Pleurx Drainage Kits. | ||
| Intended use | ||
| The Pleurx Peritoneal Catheter System is intended for intermittent, long term | ||
| drainage of symptomatic, recurrent, malignant ascites that does not respond to | ||
| medical management of the underlying disease, for the palliation of symptoms | ||
| related to recurrent malignant ascites and for peritoneal placement only. |
The Pleurx Drainage Kits and Drainage Line Set are indicated for use with either
the Pleurx Peritoneal Catheter or the Pleurx Pleural Catheter for intermittent
drainage. The Drainage Line Kit is used to drain fluid using standard wall
suction, water seal drainage system, vacuum bottle or other appropriate method.
The Pleurx Drainage Bag is indicated for use only with the Pleurx Peritoneal
Drainage Catheter for intermittent drainage.
The Pleurx Dressing Kits are indicated for dressing of a catheter and exit site.
The Pleurx Catheter Insertion Stylet is intended to aid in the percutaneous
insertion of the Pleurx Catheter into the peritoneal space. | | |
| SUMMARY OF THE TECHNOLOGICAL CHARACTERISTICS OF THE DEVICE COMPARED
TO THE PREDICATE DEVICE | | |
| Characteristic | New Device | Predicates:
CareFusion Pleurx Peritoneal Catheter
Kit and Drainage Kits (K051711)
Bard Aspira Peritoneal Catheter
System (K110396) |
| Catheter Description | Internal: fenestrations, radiopaque
markings & cuff
External: valve | Same |
| Method | Percutaneously tunneled - indwelling | Same |
| Means of Drainage | Wall suction, water seal drainage
system, portable suction, vacuum
bottles or other appropriate method | Wall suction, water seal drainage system,
vacuum bottles, syringe, drainage bag or
other appropriate method |
4
K113854 Pzgz-2gz3
CareFusion – December 2011 - Traditional 510(k): Pleurx Peritoneal Catheter System
Image /page/4/Picture/2 description: The image shows the logo for CareFusion. The logo consists of a circular graphic on the left and the word "CareFusion" on the right. The graphic is a stylized design with curved lines inside a circle. The text "CareFusion" is in a bold, sans-serif font.
5
K11 3854 Pgz 3/3
CareFusion – December 2011 - Traditional 510(k): Pleurx Peritoneal Catheter System
Image /page/5/Picture/2 description: The image contains the logo for CareFusion. The logo consists of a circular icon to the left of the company name. The icon appears to be a stylized representation of interconnected shapes within a circle. The text "CareFusion" is written in a bold, sans-serif font.
| PERFORMANCE DATA | |
|---|---|
| SUMMARY OF NON-CLINICAL TESTS CONDUCTED FOR DETERMINATION OF | |
| SUBSTANTIAL EQUIVALENCE | |
| Performance Test Summary | |
| Characteristic | Standard/Test/FDA Guidance |
| Biocompatibility | ISO 10993-1:2009 Biological evaluation of Medical Devices Part 1: Evaluation and |
| Testing | |
| Residuals | ISO 10993-7:2008 Biological evaluation of Medical Devices Part 7: Ethylene Oxide |
| Sterilization Residuals | |
| Performance | EN 1617:1997 Sterile Drainage Catheters and Accessory Devices for Single Use |
| Performance | EN 1618:1997 Catheters Other Than Intravascular Catheters - Test Methods for |
| Common Properties | |
| Performance | ANSI/AAMI/ISO 11607-1,2:2006 Packaging for Terminally Sterilized Medical Devices |
| Performance | ISO 11138-1,2:2006 Sterilization of healthcare products - Biological Indicators |
| Performance | ISO 11737-1,2:2006 Sterilization of Medical Devices - Microbiological Methods Part |
| 1 & 2 | |
| Performance | ISO 11135:2007 Medical Device, Validation and Routine Control of Ethylene Oxide |
| Sterilization | |
| Performance | ISO 594-1:1986 Conical Fittings with 6% (Luer) Taper for Syringes, Needles and |
| Certain Other Medical Equipment - Part 1: General Requirements | |
| Performance | ISO 594-2:1998 Conical Fittings with 6% (Luer) Taper for Syringes, Needles and |
| Certain Other Medical Equipment - Part 2: Lock Fittings | |
| SUMMARY OF CLINICAL TESTS CONDUCTED FOR DETERMINATION OF SUBSTANTIAL | |
| EQUIVALENCE AND/OR OF CLINICAL INFORMATION | |
| N/A - No clinical tests were conducted for this submission | |
| CONCLUSIONS DRAWN FROM NON-CLINICAL AND CLINICAL DATA |
The results of the non-clinical tests show that the CareFusion Pleurx Periloneal Catheter System meets or exceed all performance requirements, and are substantially equivalent to the predicate devices.